中华妇产科杂志
中華婦產科雜誌
중화부산과잡지
CHINESE JOUNAL OF OBSTETRICS AND GYNECOLOGY
2010年
12期
913-916
,共4页
杨武威%祝宝让%李静%夏文秀%刘滢%盖绿华%周洁敏%孙继芳
楊武威%祝寶讓%李靜%夏文秀%劉瀅%蓋綠華%週潔敏%孫繼芳
양무위%축보양%리정%하문수%류형%개록화%주길민%손계방
子宫肿瘤%平滑肌瘤%超声疗法%导管消融术%治疗结果
子宮腫瘤%平滑肌瘤%超聲療法%導管消融術%治療結果
자궁종류%평활기류%초성요법%도관소융술%치료결과
Uterine neoplasms%Leiomyoma%Ultrasonic therapy%Catheter ablation%Treatment outcome
目的 探讨超声消融治疗子宫肌瘤的近期常见并发症及其影响因素,为合理选择适应证、减少并发症提供理论依据.方法 回顾性分析超声消融治疗的子宫肌瘤患者171例(共231个肌瘤)的临床资料,分类总结治疗后近期的常见并发症,分析其影响因素.结果 超声消融治疗子宫肌瘤的常见并发症有:下腹疼痛71.9%(123/171)、阴道血性分泌物17.5%(30/171)、骶尾部和(或)臀部疼痛8.2%(14/171)、治疗区域皮肤水疱7.6%(13/171)、下肢疼痛4.7%(8/171)、血尿2.9%(5/171)、发热1.8%(3/171)等,无严重并发症发生.多重logistic回归多因素分析显示,下腹疼痛的影响因素有:肌瘤体积、治疗时间、平均功率(P<0.05);骶尾部和(或)臀部疼痛的影响因素有:肌瘤的位置[子宫后壁肌瘤治疗后,骶尾部和(或)臀部疼痛发生率高于肌瘤位于其他位置者,P<0.05];阴道血性分泌物的影响因素有:治疗时间、肌瘤类型(黏膜下>肌壁间>浆膜下,P<0.05);治疗区域皮肤水疱的影响因素有:治疗时间(P<0.05);下肢疼痛、血尿、发热的各影响因素间比较,差异无统计学意义(P>0.05).结论 超声消融治疗子宫肌瘤最常见的并发症为下腹疼痛,治疗功率和治疗时间可能是影响并发症发生的重要因素.
目的 探討超聲消融治療子宮肌瘤的近期常見併髮癥及其影響因素,為閤理選擇適應證、減少併髮癥提供理論依據.方法 迴顧性分析超聲消融治療的子宮肌瘤患者171例(共231箇肌瘤)的臨床資料,分類總結治療後近期的常見併髮癥,分析其影響因素.結果 超聲消融治療子宮肌瘤的常見併髮癥有:下腹疼痛71.9%(123/171)、陰道血性分泌物17.5%(30/171)、骶尾部和(或)臀部疼痛8.2%(14/171)、治療區域皮膚水皰7.6%(13/171)、下肢疼痛4.7%(8/171)、血尿2.9%(5/171)、髮熱1.8%(3/171)等,無嚴重併髮癥髮生.多重logistic迴歸多因素分析顯示,下腹疼痛的影響因素有:肌瘤體積、治療時間、平均功率(P<0.05);骶尾部和(或)臀部疼痛的影響因素有:肌瘤的位置[子宮後壁肌瘤治療後,骶尾部和(或)臀部疼痛髮生率高于肌瘤位于其他位置者,P<0.05];陰道血性分泌物的影響因素有:治療時間、肌瘤類型(黏膜下>肌壁間>漿膜下,P<0.05);治療區域皮膚水皰的影響因素有:治療時間(P<0.05);下肢疼痛、血尿、髮熱的各影響因素間比較,差異無統計學意義(P>0.05).結論 超聲消融治療子宮肌瘤最常見的併髮癥為下腹疼痛,治療功率和治療時間可能是影響併髮癥髮生的重要因素.
목적 탐토초성소융치료자궁기류적근기상견병발증급기영향인소,위합리선택괄응증、감소병발증제공이론의거.방법 회고성분석초성소융치료적자궁기류환자171례(공231개기류)적림상자료,분류총결치료후근기적상견병발증,분석기영향인소.결과 초성소융치료자궁기류적상견병발증유:하복동통71.9%(123/171)、음도혈성분비물17.5%(30/171)、저미부화(혹)둔부동통8.2%(14/171)、치료구역피부수포7.6%(13/171)、하지동통4.7%(8/171)、혈뇨2.9%(5/171)、발열1.8%(3/171)등,무엄중병발증발생.다중logistic회귀다인소분석현시,하복동통적영향인소유:기류체적、치료시간、평균공솔(P<0.05);저미부화(혹)둔부동통적영향인소유:기류적위치[자궁후벽기류치료후,저미부화(혹)둔부동통발생솔고우기류위우기타위치자,P<0.05];음도혈성분비물적영향인소유:치료시간、기류류형(점막하>기벽간>장막하,P<0.05);치료구역피부수포적영향인소유:치료시간(P<0.05);하지동통、혈뇨、발열적각영향인소간비교,차이무통계학의의(P>0.05).결론 초성소융치료자궁기류최상견적병발증위하복동통,치료공솔화치료시간가능시영향병발증발생적중요인소.
Objective To analysis complications and its associated risk factors of high intensity focused ultrasound (HIFU) in treatment of uterine leiomyoma for selecting rationale indicated patients and reducing complications. Methods Medical documents of 171 patients with 231 leiomyomas in total treated by HIFU were studied retrospectively. Common complications were categorized and analyzed, the relationship between risk factors and complications were studied. Results Common complications in treatment of uterine leiomyomas by HIFU were 71.9% (123/171) of abdominal pain, 17.5% (30/171) of vaginal bloody discharge, 8.2% (14/171) of sacroiliac or buttock pain, 7. 6% (13/171) of skin blister,4. 7% (8/171) of leg pain, 2. 9% (5/171) of hematuria and 1.8% (3/171) of febrile. By logistic regression analysis, the factor correlated with abdominal pain included diameter of uterine leiomyomas,sonication time and average power (P < 0. 05). The factor correlated with sacroiliac or buttock pain was uterine leiomyomas located in posteriors of uterine wall(P <0. 05); the factors correlated with vaginal bloody discharge were sonication time and type of uterine leiomyomas (submucous > intramural > subserous, P <0. 05); the factors correlated with skin blister was sonication time (P < 0. 05). There were no statistical relationship between multiple factors and leg pain, hematuria, febrile (P > 0. 05). Conclusion The modality of high-power and short-term treatment might reduce complications of HIFU ablation.